BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 26452467)

  • 1. Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
    Stucki A; Cottagnoud M; Winkelmann V; Schaffner T; Cottagnoud P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2249-52. PubMed ID: 17371817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
    Muri L; Grandgirard D; Buri M; Perny M; Leib SL
    J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin.
    Gerber J; Smirnov A; Wellmer A; Ragheb J; Prange J; Schütz E; Wettich K; Kalich S; Nau R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2169-72. PubMed ID: 11408247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining antibiotic with anti-TLR2/TLR13 therapy prevents brain pathology in pneumococcal meningitis.
    Dyckhoff-Shen S; Masouris I; Islam H; Hammerschmidt S; Angele B; Marathe V; Buer J; Völk S; Pfister HW; Klein M; Koedel U; Kirschning CJ
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae meningitis in an adult with normal cerebrospinal fluid.
    Montassier E; Trewick D; Batard E; Potel G
    CMAJ; 2011 Oct; 183(14):1618-20. PubMed ID: 21543306
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis.
    Blaser C; Wittwer M; Grandgirard D; Leib SL
    PLoS One; 2011 Mar; 6(3):e17840. PubMed ID: 21412436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive treatments for pneumococcal meningitis: a systematic review of experimental animal models.
    Koning R; van Roon MA; Brouwer MC; van de Beek D
    Brain Commun; 2024; 6(3):fcae131. PubMed ID: 38707710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 30-year perspective of low-dose dexamethasone, a single dose of mannitol and antiseizures prophylaxis on the prognosis of pneumococcal meningitis.
    Cabellos C; Guillem L; Pelegrin I; Tubau F; Ardanuy C; Gudiol F; Ariza J; Viladrich PF
    Infect Dis (Lond); 2024 Jun; ():1-9. PubMed ID: 38922314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study.
    Chavanet P; Fournel I; Bourredjem A; Piroth L; Blot M; Sixt T; Binquet C
    BMJ Open; 2023 Jul; 13(7):e073032. PubMed ID: 37491088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Pharmaceutical Effects of the Antibiotic Daptomycin.
    Ye Y; Xia Z; Zhang D; Sheng Z; Zhang P; Zhu H; Xu N; Liang S
    Biomed Res Int; 2019; 2019():8609218. PubMed ID: 31263709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.
    Vivas M; Force E; Tubau F; El Haj C; Ariza J; Cabellos C
    Int J Antimicrob Agents; 2015 Jul; 46(1):28-32. PubMed ID: 25813395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    McCracken GH
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotherapy as first choice in infectious meningitis].
    Cohen R; de La Rocque F; Varon E; Geslin P
    Pediatrie; 1993; 48(1):37-49. PubMed ID: 8392691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
    Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
    J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
    Grandgirard D; Schürch C; Cottagnoud P; Leib SL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.